Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Shares Outstanding (2016 - 2025)

Sangamo Therapeutics (SGMO) has 5 years of Shares Outstanding data on record, last reported at $69.1 million in Q4 2014.

  • For Q4 2014, Shares Outstanding rose 10.95% year-over-year to $69.1 million; the TTM value through Dec 2014 reached $69.1 million, up 10.95%, while the annual FY2014 figure was $69.1 million, 10.95% up from the prior year.
  • Shares Outstanding reached $69.1 million in Q4 2014 per SGMO's latest filing, up from $62.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $69.1 million in Q4 2014 and bottomed at $45.4 million in Q4 2010.
  • Average Shares Outstanding over 5 years is $56.5 million, with a median of $53.1 million recorded in 2012.
  • Peak YoY movement for Shares Outstanding: grew 0.96% in 2012, then rose 17.31% in 2013.
  • A 5-year view of Shares Outstanding shows it stood at $45.4 million in 2010, then increased by 15.82% to $52.6 million in 2011, then increased by 0.96% to $53.1 million in 2012, then increased by 17.31% to $62.2 million in 2013, then rose by 10.95% to $69.1 million in 2014.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $69.1 million in Q4 2014, $62.2 million in Q4 2013, and $53.1 million in Q4 2012.